Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation

Guisheng Zhao, Marie Claude Monier-Faugere, Moises Chris Langub, Zhaopo Geng, Toshiyuki Nakayama, J. Wesley Pike, Steven D. Chernausek, Clifford J. Rosen, Leah Rae Donahue, Hartmut H. Malluche, James A. Fagin, Thomas L. Clemens

Research output: Contribution to journalArticlepeer-review

Abstract

Insulin-like growth factor I (IGF-I) is an important growth factor for bone, yet the mechanisms that mediate its anabolic activity in the skeleton are poorly understood. To examine the effects of locally produced IGF-I in bone in vivo, we targeted expression IGF-I to osteoblasts of transgenic mice using a human osteocalcin promoter. The IGF-I transgene was expressed in bone osteoblasts in OC-IGF-I transgenic mice at high levels in the absence of any change in serum IGF-I levels, or of total body growth. Bone formation rate at the distal femur in 3-week-old OC-IGF-I transgenic mice was approximately twice that of controls. By 6 weeks, bone mineral density as measured by dual energy x-ray, and quantitative computed tomography was significantly greater in OC-IGF-I transgenic mice compared with controls. Histomorphometric measurements revealed a marked (30%) increase femoral cancellous bone volume in the OC-IGF-I transgenic mice, but no change in the total number of osteoblasts or osteoclasts. Transgenic mice also demonstrated an increase in the osteocyte lacunea occupancy, suggesting that IGF-I may extend the osteocyte life span. We conclude that IGF-I produced locally in bone osteoblasts exerts its anabolic effect primarily by increasing the activity of resident osteoblasts.

Original languageEnglish (US)
Pages (from-to)2674-2682
Number of pages9
JournalEndocrinology
Volume141
Issue number7
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation'. Together they form a unique fingerprint.

Cite this